Technical corrections only. The changes between v2 and v3 reflect the bill's procedural movement from the House of Representatives to the Senate, including updated legislative status and clerical attestations. There are no substantive policy changes to the bill text itself.
Vietnam Veterans Liver Fluke Cancer Study Act
- Sponsor
- Rep. LaLota, Nick [R-NY-1]
- Committees
- Veterans' Affairs Committee (primary)
- Last action
- Apr 8, 2025
Bottom line
The bill mandates a study and ongoing tracking of a specific cancer in Vietnam veterans and makes a minor, one-month extension to a veterans' pension payment limitation.
What it actually does
This bill directs the Secretary of Veterans Affairs (VA), in consultation with the Centers for Disease Control and Prevention (CDC), to conduct an epidemiological study on the prevalence of cholangiocarcinoma (bile duct cancer) in Vietnam-era veterans who served in the Vietnam theater of operations. The study will identify incidence rates and demographic breakdowns. It also requires the VA to track the prevalence of this cancer ongoingly and report findings to Congress. Additionally, the bill extends a specific limitation on veterans' pension payments by one month, from November 30, 2031, to December 31, 2031.
Proponents argue
Supporters argue that this bill is a crucial step in understanding and addressing a potentially overlooked health issue affecting Vietnam veterans. They contend that a dedicated epidemiological study is necessary to determine the true prevalence of cholangiocarcinoma, which has been linked to liver fluke infections common in Southeast Asia, and to inform future healthcare policies and support for affected veterans. The reporting requirements ensure transparency and accountability.
Opponents contend
Critics might argue that while the study is well-intentioned, it represents a narrow focus on one specific health issue when veterans face a multitude of complex health challenges, potentially diverting resources from broader, more comprehensive health initiatives. Some might also raise concerns about the administrative burden on the VA and CDC to conduct and continuously track this data without explicit new funding mechanisms. Regarding the pension provision, while a one-month extension is minor, any limitation on veterans' benefits could draw criticism from advocates if the underlying policy is viewed as detrimental.
The bill is very short and straightforward, making it highly accessible for any reader to understand its provisions quickly.
Section 2(a)
Epidemiological Study on Cholangiocarcinoma in Vietnam Veterans
This provision mandates the Department of Veterans Affairs, in collaboration with the Centers for Disease Control and Prevention, to initiate an epidemiological study within 120 days of the bill's enactment. The study will investigate the occurrence of cholangiocarcinoma (a type of bile duct cancer) among veterans who served in the Vietnam theater during the Vietnam era. It requires comparing incidence rates in this veteran group to the general U.S. population and analyzing demographic factors like age, gender, race, ethnicity, and geographic location at diagnosis.
Supporters argue
Proponents argue that this study is essential for recognizing and addressing the unique health challenges faced by Vietnam veterans, particularly those potentially exposed to liver flukes. They believe that understanding the prevalence of cholangiocarcinoma is a matter of justice and provides critical data for targeted healthcare interventions and support.
Critics contend
No specific opposition is typically raised against studies aimed at improving veterans' health. However, some might express concern that focusing on one specific cancer, while important, might divert resources or attention from other pressing health issues affecting the broader veteran population.
Tradeoffs
The primary tension involves resource allocation: dedicating VA and CDC resources to this specific study means those resources are not available for other research or healthcare initiatives. There is also the challenge of conducting a retrospective epidemiological study over a long period, relying on historical data which may have limitations.
Section 2(b) and 2(c)
Reporting and Continued Tracking of Cholangiocarcinoma
These provisions require the VA Secretary to submit an initial report to Congress within one year of the study's completion, detailing its results and offering recommendations for administrative or legislative actions. Furthermore, the VA is directed to continuously monitor the prevalence of cholangiocarcinoma in covered Vietnam-era veterans using the Veterans Affairs Central Cancer Registry and provide updates to Congress through periodic follow-up reports.
Section 3
Extension of Certain Limitation of Pension Payments
This provision makes a technical amendment to section 5503(d)(7) of title 38, United States Code. It changes the expiration date of a specific limitation on veterans' pension payments from November 30, 2031, to December 31, 2031. This effectively extends an existing restriction or condition on pension payments by one month.
This section extends the expiration date of a specific limitation on veterans' pension payments, as outlined in 38 U.S.C. 5503(d)(7), by one month, from November 30, 2031, to December 31, 2031.
Section 3
Why it matters:This is likely a standard legislative practice for technical corrections or minor extensions that are not the main focus of a bill. It could be a 'rider' or a minor provision added to a relevant bill for efficiency, rather than a deliberate attempt to hide a controversial policy.
Case for: Proponents would argue it's a necessary technical adjustment or a minor fiscal measure that aligns with existing policy frameworks. It ensures continuity of a specific budgetary or administrative control for a brief, additional period.
Case against: Critics might argue that any limitation on veterans' pensions should be transparently debated, and extending it, even for a month, without clear justification within the bill text, could be seen as an incremental erosion of benefits or a lack of full accountability.
Estimated impact: The impact is a one-month extension of an existing limitation on pension payments. Without knowing the specific limitation, the precise fiscal or beneficiary impact cannot be quantified, but it is likely minor.